The Correlation between ¹H-MR Spectroscopy and Clinical Manifestation with Tuberous Sclerosis Complex

Abstract

Tuberous sclerosis complex (TSC) is an autosomal dominant neurocutaneous disease. Cortical tubers are one of the standard intracranial hallmarks of TSC, they comprise subependymal hamartomas protruding into the ventricles, cortical and white matter hamartomas, and giant cell tumors. The clinical course of TSC varies from asymptomatic to severe, with epileptic seizures and psychomotor retardation. We discuss here the correlation between clinical manifestation and features on ¹H-MR spectroscopy (¹H-MRS) of the white matter involving cortical tubers in patients with TSC. Statistical analysis of the N-acetylaspartate (NAA), choline (Cho) and myoinositol (mI)/creatinine (Cr) ratios between tubers and normal controls showed decreased NAA/Cr and increased mI/Cr ratios (P<0.05) in tubers, but no significance difference in Cho/Cr. The significance of the clinical appearance is associated with a decreased ratio of NAA/Cr in tubers with TSC. An elevated ratio of mI/Cr in tuber does not parallel the severity of the clinical features of TSC. These findings suggest that ¹H-MRS may be useful for the evaluation of the clinical severity and prognostic diagnosis of TSC.

Key words

Tuberous sclerosis complex (TSC) - MR imaging - MR spectroscopy - N-acetylaspartate - myoinositol - choline

References

• 1 Aasly J, Silfvenius H, Aas TC, Sonnewald U, Olivecroma M, Juul R. et al . Proton magnetic resonance spectroscopy of brain biopsies from patients with intractable epilepsy.  Epilepsy Res. 1999;  35 211-217
• 2 Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex.  N Engl J Med. 2006;  355 1345-1356
• 3 Goodman M, Lamm SH, Engel A, Shepherd CW, Houser OW, Gomez MR. Cortical tuber count: a biomarker indicating neurologic severity of tuberous sclerosis complex.  J Child Neurol. 1997;  12 85-90
• 4 Hyman MH, Whittemore VH. National Institutes of Health consensus conference tuberous sclerosis complex.  Arch Neurol. 2000;  57 662-664
• 5 Imamura A, Matsuo N, Okuda M, Morita H, Iwata M, Yamazaki Y. et al . Serial MR imaging and ¹H-MR spectroscopy of unidentified bright objects in a case of neurofibromatosis type 1.  Brain Dev. 2005;  27 595-597
• 6 Jones AC, Daniells CE, Snell RG, Tachataki M, Idziaszczyk SA, Krawczak M. et al . Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis.  Hum Mol Genet. 1997;  6 2155-2161
• 7 Kendall BE, Demaerel P. Imaging of pediatric and congenital brain disease.  Current Opinion in Radiology. 1992;  4 28-37
• 8 Li LM, Cendes F, Bastos C, Andermann F, Dubeau F, Arnold DL. Neuronal metabolic dysfunction in patients with cortical development malformations. A proton magnetic resonance spectroscopic imaging study.  Neurology. 1998;  50 755-759
• 9 Mizuno S, Takahashi Y, Kato Z, Goto H, Kondo N, Hoshi H. Magnetic resonance spectroscopy of tubers in patients with tuberous sclerosis.  Acta Neurol Scand. 2000;  102 175-178
• 10 Mukonoweshuro W, Wilkinson ID, Griffiths PD. Proton MR Spectroscopy of cortical tubers in adults with tuberous sclerosis complex.  Am J Neuroradiol. 2001;  22 1920-1925
• 11 Nabboutt R, Santos M, Roland Y, Delalande O, Durac O, Chiron C. Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis.  J Neurol Neurosurg Psychiatry. 1999;  66 370-375
• 12 Norfay JF, Darling C, Byrd S, Ross BD, Schwalm C, Miller R. et al . Short TE proton MRS and neurofibromatosis type 1 intracranial lesion.  J Comput Asssit Tomo. 1999;  23 994-1003
• 13 Sener RN. Infantile tuberous sclerosis change in the brain: proton MR spectroscopy findings.  Comut Med Imag Graph. 2000;  24 19-24
• 14 Sharma MS, Suri A, Shah T, Ralte A, Sarkar C, Gupta V. et al . Intraventricular glioneuronal hamartama: histopathological correlation with magnetic resonance spectroscopy.  J Neuro-Oncology. 2005;  74 325-328
• 15 Tarasów E, Kubas B, Walecki J. MR proton spectroscopy in patients with CNS involvement in Bourneville's disease.  Med Sci Monit. 2001;  4 762-765

Correspondence